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1. Introduction 
Morbid obesity is a chronic, lifelong, multifactorial, congenital disorder characterised by 
excessive fat deposits and associated medical, psychological, physical, social, and 
economic problems. It is also a significant health threat. The extra weight puts unusual 
stress on all parts of the body. It raises your risk of diabetes, stroke, heart disease, kidney 
disease, and gallbladder disease. Conditions such as high blood pressure and high 
cholesterol, which were once thought to mainly affect adults, are often seen in children 
who are obese. Obesity may also increase the risk for some types of cancer. Persons who 
are obese are more likely to develop osteoarthritis and sleep apnea. Obesity is the second 
leading cause of preventable death after smoking. A combination of genetics, 
environmental issues, and behavioral factors may contribute to the condition (Breznikar & 
Dinevski, 2009). 
Nonsurgical treatment has relapse rates of up to 90%, irrespective of the choice of 
conservative treatment (Council of Scientific Affairs, 1988). As early as 1991, the U.S. 
National Institute of Health issued a statement recognizing the known lack of success with 
conservative forms of treatment, nothing that operations to constrict or bypass the stomach 
were justified for fully informed and consenting patients and constituted an acceptable risk 
(National Institute of Health, 1985, Oppert & Rolland-Cachera, 1998). 
In 1954, Kremen and Linner introduced jejunoileal bypass. Modifications in the original 
procedures and the development of new techniques have led to 3 basic concepts for bariatric 
surgery, as follows: (1) gastric restriction by gastric banding (vertical-banded gastroplasty 
and adjustable banding), (2) gastric restriction with mild malabsorption (Roux-en-Y gastric 
bypass), and (3) a combination of mild gastric restriction and malabsorption (duodenal 
switch) (Masson et al., 1997, Belachew et al., 1997, Gravante et al. 2007).  
Bariatric surgery can be undertaken by open and laparoscopic techniques. The latter has 
become the more popular approach because of its proven (and now well-known) 
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advantages. GBP is currently the most popular procedure. More than 80% of bariatric 
procedures in the USA are GBP. It has earned the reputation of being the criterion standard 
against which other procedures are compared. The procedure has restrictive and 
malabsorptive components. GBP provides a substantial amount of dietary restriction. The 
restrictive element of the surgery consists of the creation of a small gastric pouch  with a 
small outlet that, on distention by food, causes the sensation of satiety. In addition, GBP 
provides a small-to-moderate degree of intentional malabsorption due to the separation of 
food, which passes through the Roux alimentary limb of the Y, from the biliopancreatic 
secretions, which pass through the biliopancreatic limb of the Y. The degree of 
malabsorption can be adjusted by modifying the length of the alimentary and 
biliopancreatic limbs. 
The diversity of clinical- and occult obesity-related comorbidities necessitates a 
multidisciplinary-team approach in the preoperative evaluation of a morbidly obese the 
patient: this evaluation enhances outcome. Preoperative cardiac, pulmonary, psychiatric, 
and endocrine evaluations may be necessary. These evaluations help to exclude patients 
who may not benefit from surgery. They simultaneously optimize those considered to be 
good candidates for this type of surgery. Patients should meet all necessary criteria for 
general surgery.  
The contraindications specific to bariatric surgery are: 
1. Absence of periods of identifiable medical management 
2. A patient who cannot participate in prolonged follow-up 
3. Non-stabilized psychotic disorders, severe depression and personality disorders (unless 
specifically advised by a psychiatrist experienced in obesity) 
4. Alcohol abuse and/or drug dependencies 
5. Diseases threatening life in the short-term 
6. Patients who cannot care for themselves and have no long-term support from their 
family or social service that warrant such care.  
The indications for bariatric surgery are: patients aged 18–60 years with a body mass index 
(BMI) >40 kg/m2 or with a BMI 35–40 kg/m2 with a comorbidity in which surgically 
induced weight loss is expected to improve the disorder (e.g., metabolic disorders, cardio-
respiratory disease, severe joint disease, obesity-related severe psychological problems). The 
BMI criterion may be the current BMI or a documented previous BMI of identical severity. 
Bariatric surgery is indicated in patients who exhibit substantial weight loss in a 
conservative treatment program but who started to regain weight. To be considered for 
surgery, patients must have failed to lose weight or to maintain long-term weight loss 
despite appropriate medical care. Patients must have shown compliance with medical 
appointments. The indication for bariatric surgery for age >60 years or <18 years should be 
considered on an individual basis.  
Preoperative consultation helps in obtaining a detailed diet history and in explaining 
preoperative and postoperative diet protocol. At our facility, patient preparation for surgery 
consisted of a detailed explanation (in written and oral form) of the developmental aspect of 
laparoscopic GBP and its benefits and risks. These included short- and long-term 
complications, side effects, nutritional sequelae, and the possibility of conversion to an open 
procedure. Antibiotics were administered perioperatively. Prophylaxis against venous 
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thrombosis and pulmonary emboli consisted of perioperative pneumatic compression 
devices and low-dose heparin (s.c.). 
After GBP, patients must remain on a high-protein, low-fat diet supplemented with 
multivitamins, iron, and calcium. Patients must modify their eating habits by avoiding 
“chewy” meats and other foods that may inhibit normal emptying of their stomach pouch. 
Nutritional and metabolic blood tests need to be carried out frequently (at 6 months after 
surgery, 12 months after surgery, and annually thereafter).  
Outcomes related to changes in comorbidities, quality of life, and patient satisfaction are 
assessed for patients with 1 year or more of follow-up. The Bariatric Analysis and Reporting 
Outcome System (BAROS) was introduced to evaluate bariatric procedures and to compare 
them worldwide. It consists of a Moorehead Quality of Life (QoL) questionnaire, and 
documentation of excess weight loss (EWL), medical conditions, complications, and 
reoperations. 
2. Bariatric procedures, gastric bypass (GBP) 
GBP is currently the most popular procedure. It has earned the reputation of being the 
criterion standard, against which other procedures are compared. The procedure has both 
a restrictive component and a malabsorptive component. GBP provides a substantial 
amount of dietary restriction. The restrictive element of the operation consists of the 
creation of a small gastric pouch (approximately 20 mL in volume) with a small outlet 
that, on distention by food, causes the sensation of satiety. In addition, gastric bypass 
provides a small-to-moderate degree of intentional malabsorption due to the separation of 
food, which passes through the alimentary limb of the Y, from the biliopancreatic 
secretions, which pass through the biliopancreatic limb of the Y. The degree of 
malabsorption can be adjusted by modifying the length of the alimentary and 
biliopancreatic limbs. 
For all bariatric procedures, pure reversal without conversion to another bariatric procedure 
is almost certainly followed by a return to morbid obesity. Gastric bypass can be reversed, 
though this is rarely required. Laparoscopic Roux-en Y gastric bypass results in substantial 
weight loss and resolves more than 80% of cases of type 2 diabetes. The investigators 
suggest that this bariatric operation should be considered the standard of care for morbidly 
obese type 2 diabetics5. 
Vitamin D deficiency and elevated PTH are common following GBP and progress over time. 
There is a significant incidence of secondary hyperparathyroidism in short-limb GBP 
patients, even those with vitamin D levels ≥30 ng/mL, suggesting selective Ca2+ 
malabsorption. Thus, calcium malabsorption is inherent to gastric bypass. Careful calcium 
and vitamin D supplementation and long-term screening are necessary to prevent 
deficiencies and the sequelae of secondary hyperparathyroidism. 
Laparoscopic Roux-en-Y gastric bypass is a major elective surgical procedure. The risks are 
as follows: mortality (1-2% of patients), mainly due to pulmonary embolism or 
gastrointestinal leak, wound infections, gastrojejunal stomal stricture, marginal ulcers, 
internal hernia, roux limb ischemia, blow-out of the stomach remnant, long-term nutrient 
deficiencies (eg, vitamin B12, folate, iron).   
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2.1 Preoperative details 
The diversity of clinical and occult obesity-related comorbidities necessitates a 
multidisciplinary team approach in the preoperative evaluation of the patient who is morbidly 
obese. This evaluation enhances the postoperative outcome. Preoperative cardiac, pulmonary, 
psychiatric, and endocrine evaluations may be necessary. These evaluations help to exclude 
patients who may not benefit from surgery; at the same time, they optimize those considered 
being potential good candidates. Preoperative nutritional consultation helps in obtaining a 
detailed diet history and in explaining preoperative and postoperative diet protocol. At our 
facility, patient preparation for surgery consisted of a detailed explanation in written and oral 
form of the developmental aspect of laparoscopic GBP and its benefits and risks, including 
short- and long-term complications, side effects, nutritional sequelae, and the possibility of 
conversion to an open procedure. Perioperative antibiotics were administered. Prophylaxis 
against venous thrombosis and pulmonary embolus consisted of perioperative pneumatic 
compression devices and low-dose subcutaneous heparin. 
2.2 Postoperative details 
After surgery, patients must remain on a high-protein, low-fat diet supplemented with 
multivitamins, iron, and calcium. Patients must modify their eating habits by avoiding 
chewy meats and other foods that may inhibit normal emptying of their stomach pouch. 
Nutritional and metabolic blood tests need to be performed frequently (at 6 months after 
surgery, 12 months after surgery, and annually thereafter). 
We have a monthly support group meeting, where the evaluation of the results is 
monitored. To evaluate the bariatric procedures and to compare them worldwide, Bariatric 
Analysis and Reporting Outcome System (BAROS) was introduced (Oria & Moorehead, 
1998). It consists of Moorehead Quality of Life questionnaire (QoL), EWL, medical 
condition, complications, and reoperations (Table 1). Total score is between 1 and 9 in the 
group with comorbidities and between 0 and 6 in the group with no comorbidities (Table 2), 
each divided in 5 classes: bad, acceptable, good, very good, and excellent. 
Outcomes related to changes in comorbidities, quality of life, and patient satisfaction were 
assessed for patients with 1 year or more of follow-up. The Moorehead-Ardelt Quality of 
Life Questionnaire specific for bariatric surgery was administered according to the protocol 
to assess quality of life changes. 
2.3 Material and methods 
Surgical procedures were performed at Slovenj Gradec General Hospital and Celje General 
Hospital, Slovenia. An extensive preoperative evaluation consisting of a history and 
physical examination, nutritional and psychiatric evaluation, and indicated specialty 
consultations was performed on all patients. Laboratory evaluation included complete 
blood count, serum chemistries, and thyroid function testing.  
The surgical technique was a modification of the technique described by Wittgrove et al. 
(1994). The patient was placed in a supine position with the surgeon in between the legs, 
and two monitors above the patient’s shoulders. After creation of carbon dioxide 
pneumoperitoneum (15 mmHg) using the Veress needle technique or entering the abdomen 
www.intechopen.com
Gastric Banding and Bypass for Morbid Obesity – 
Preoperative Assessment, Operative Techniques and Postoperative Monitoring 161 
without gas, just with the optic trocar, ports were placed at the level of mesogastrium; the 
first one for the camera approximately 12 cm from the xyphoid. The operating table was 
placed in a steep reverse Trendelenburg position. To expose the esophagus and stomach, the 
liver retractor was placed through the inferior right subcostal port, and the left lateral 
segment of the liver was elevated. A 30 ml gastric pouch was created. The endo-linear 
stapler, 45-mm in length with 3.8-mm staples, was inserted and applied three or four times 
to staple and cut the gastric pouch with three rows of staples on each side. A 
gastroenteroanastomosis was than created 40 – 60 cm from the ligament of Treitz using 
either a circular end-to-end anastomosis stapled technique (first 20 cases) or a linear stapled 
technique (last 80 cases). The Roux limb was then measured 100 cm distally, or 150 cm 
distally for the superobese patients. A stapled side-to-side anastomosis was created with the 
proximal jejunal limb using  the endo-linear stapler, 45-mm in length with 2.5-mm, white 
staples. The enterotomy sites were closed with running suture. All the anastomoses were 
tested with methylene blue. Lastly, the afferent loop close to the gastroenteroanastomosis 
was divided with a white cartridge of the linear stapler.  
From February 2007 until March 2010, we performed 100 laparoscopic GBP surgeries. 
Patients were 42.2 years old on average (range 18.9 to 63.3). 87 females were 42.3 years old 
on average (range 18.9 to 63.3) and 13 males were 41.5 years old on average (range 26.4 to 
53.0). Their BMI was 42.6 on average (range 33.4 to 72.3); females 42.7 (range 33.7 to 72.3), 
males 42.1 (range 33.4 to 49.6). 
2.4 Results 
The mean follow-up was 9.1 months (range 2 – 39 months); 53 patients had 1 or more, 17 
patients had 2 or more and 3 patients had 3 or more years of follow up. We had one 
conversion because of adhesions and one because of bleeding from injured mesentery. 
One year after the surgery, 53 patients (47 females and 5 males) lost 32.8 kg on average 
(range 7.0 to 53.0). Female patients lost 31.8 kg on average (range 7.0 to 53.0); male patients 
lost 43.0 kg (37.0 to 47.5), 17 patients lost 35.7 kg (11.0 to 57.0) after 2 years, and 3 patients 
lost 47.3 kg (43.0 to 55.0) after 3 years (Figure 1). 
Excess Weight Loss (EWL) was 69.6 % (range 12.2 to 133.4) after 1 year, 76.5% (range 21.0% 
to 108.4%) after 2, and 86.0% after 3 years (range 71.8 to 104.9) (Figure 2).  
EWL(t) = (max. weight – weight(t) ) / (max. weight – weight (BMI25)), while “t” is the time 
of the interest and weight (BMI25) is the weight of the person at BMI=25 kg/m2 
Body mass index (BMI) was reduced by 11.6 kg/m2; from an average of 42.6 before the 
operation to 31.0 at one year post-operatively (range 21.4 to 59.5). BMI was further reduced 
to 29.4 (range 23.5 to 43.5) at 2 years post-operatively, and to 27.4 at 3 years post-operatively 
(range 24.1 to 31.2) (Figure 3, Table 3). BMI= mass (kg)/(height, m )2 
A total of 137 comorbidities were identified in our 100 patients. The most common 
comorbidities included hypertension (34 %), degenerative joint disease (22%), type II 
diabetes (16%), hypercholesterolemia (7%), and asthma (7%). The comorbidities and their 
resolution are presented in Table 4. The resolution of diabetes with respect to therapy prior 
to GBP surgery is presented in Table 5.  
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Fig. 1. Weight loss 
(every line presents a patient, a dot in the line is the monitoring point, thick line is mean 
value) 
 
Fig. 2. Excess Weight Loss - EWL 
(every line presents a patient, a dot in the line is the monitoring point, thick line is mean 
value) 
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Fig. 3. BMI reduction 
(every line presents a patient, a dot in the line is the monitoring point, thick line is mean 
value) 
 
 points 
Moorehead questionnaire of QoL -3 to +3 
EWL: weight gain 
0 – 24%  
25 – 49% 
50 – 74% 
75 – 100% 
-1 
0 
+1 
+2 
+3 
Medical condition: 
worsened 
unchanged 
improved 
resolve a major comorbidity and improve others 
resolve all major comorbidities and improve others 
-1 
0 
+1 
+2 
+3 
Complications: 
major 
minor 
-1 
-0.2 
reoperation -1 
Table 1. BAROS 
The overall mean operating time for the last 50 patients was 90.6 minutes (range 55 to 195). 
Four patients had early (<30 days) major complications: leakage, ileus, stenosis of entero-
entero anastomosis, and small bowel injury. All complications were treated with an 
additional procedure. Among minor complications were two bleedings from the mesentery 
www.intechopen.com
 Advanced Bariatric and Metabolic Surgery 164 
due to a mesentery suturing, and one bleed from the staple line intraluminally. Blood 
transfusions were sufficient. A port site abscess occurred in one patient. One instance of 
Peterson's hernia, a late complication, occurred two years after the first operation when 
Peterson's space wasn't closed. The problem was solved by repositioning the small bowel 
and closing the defect. 
 
 
Patients with comorbidities 
(total score) 
Patients without comorbidities 
(total score) 
bad <1 <0 
acceptable 1 - 3 0 -1.5 
good 3 - 5 1.5 -3 
very good 5 -7 3 – 4.5 
excellent 7 - 9 4.5 - 6 
Table 2. BAROS scoring 
 
 1 year-53 pts 2 years-17 pts 3 years-3 pts 
Lost weight (kg) 
(range) 
32.8 
(7.0-53.0) 
35.7 
(11.0-57.0) 
47.3 
(43.0-55.0) 
EWL (%) 
(range) 
69.6 
(12.2-133.4) 
76.5 
(21.0-108.4) 
86.0 
(71.8-104.9 
BMI (kg/m2) 
(range) 
31.0 
(21.4-59.5) 
29.4 
(23.5-43.5) 
27.4 
(24.1-31.2) 
Table 3. Results at 1, 2, and 3 years post-operatively 
 
 all improved resolved no change no data 
Orthopedic symptoms 22 9 (40.9%) 11 (50.0%) 1 (4.5%) 1 
Hypertension 34 10 (29,4%) 23 (67,6%)  1 
Diabetes 16 6 (37,5%) 9 (56.2%)  1 
Hyperlipidemia 7 3 (42.9%) 4 (57.1%)  0 
Asthma 7 2 (28.6%) 4 (57.1%)  1 
Table 4. Comorbidities 
  
 all improved resolved months to resolution 
DM - diet 4 0 4 (100%) < 1 
DM – oral medication 7 3 (42.9%) 4 (57.1%) 10.2 (1-29) 
DM - insulin 4 3 (75.0%) 1 (25.0%) < 1 
Table 5. Resolution of diabetes with respect to therapy prior to surgery 
Three patients had a gastric bypass performed after insufficient weight loss after sleeve 
gastrectomy, and four patients had GBP surgery after gastric banding. One bypass was 
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performed because of migration of the band. Two out of four major complications (ileus and 
small bowel injury) occurred in redo procedures – after failed bandings. 50 out of 53 patients 
who were monitored for more than one year answered the Moorehead QoL questionnaire. 
The total average BAROS score was 6.5 for the group with comorbidities (range 2.8 to 9.0), 
and 3.2 for the group without comorbidities (range 0.3 to 5.0) – which is “very good” in both 
groups. 
3. Bariatric procedures, Adjustable Gastric Banding (AGB) 
The device consists of an adjustable inflatable band placed around the proximal part of the 
stomach. This creates a small gastric pouch (approximately 15 ml in volume) and a small 
stoma. Band restriction is adjustable by adding or removing saline from the inflatable band 
by a reservoir system of saline attached to the band and accessible through a port, which is 
attached by a catheter to the band. The port is placed subcutaneously in the anterior 
abdominal wall after the band is secured around the stomach. Adjustment of the band 
through the access port is an essential part of laparoscopic adjustable gastric banding 
therapy. Appropriate adjustments, performed up to 6 times annually, are critical for 
successful outcomes. Patients must chew food thoroughly to allow food to pass through the 
band. Adjusting the inflation of the cuff changes the size of the opening through which food 
passes but does not change the size of the gastric pouch; deflation of the cuff is useful when 
the outlet is obstructed. 
Weight loss after laparoscopic adjustable gastric banding is about 50-60% of excess body 
weight in approximately 2 years. AGB can be completely reversed with removal of the band, 
tubing, and port. 
Laparoscopic adjustable gastric banding was a safe and feasible technique with specific 
indications in moderately obese patients and, secondarily, in highly obese patients who are 
unfit for more invasive techniques. In patients with mild-to-moderate obesity, laparoscopic 
adjustable gastric banding appears to be significantly more effective than nonsurgical 
therapies in producing weight loss, resolving the metabolic syndrome, and improving 
quality-of-life outcomes, new study findings suggest.8,9,11 
3.1 Material & methods 
A clinical study was conducted at Slovenj Gradec General Hospital, Slovenia. We performed 
264 gastric bandings (66.5% of all bariatric procedures) between May 2005 and May 2010. 
On average, patients were 41.0 years old (range 17.2 – 68.8) and had a BMI of 42.4 kg/m2 
(range 34.5 – 59.0). There were 224 female patients (84.8%) with an average age of 41.0 
(range 19.5 – 68.8) and a BMI 42.0 kg/m2 (range 34.5 – 59.0) – table 6. Out of 264 patients, 15 
had to have the band removed because of either insufficient weight loss (6 patients, 2.3%), 
slippage (4 patients, 1.5%), migration (1 patient, 0.4%), band leakage (1 patient, 0.4%), intra 
abdominal abscess (1 patient, 0.4%), outlet obstruction (1 patient, 0.4%), and personal 
reasons (1 patient, 0.4%). 4 patients (1.5%) were lost to follow up – table 7 and 8. We 
followed 192 patients for more than one year. 155 patients (80.7%) were evaluated with 
BAROS – Bariatric Analysis and Reporting Outcome System, which is a questionnaire 
assessing the quality of life (QoL), excessive weight loss (EWL), medical conditions, and 
complications. Scoring is divided into 5 grades ranging from bad to excellent. There are 2 
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different scoring groups: a group with comorbidities (1 - 9 points) and a group without 
comorbidities (0 – 6 points). 155 of our patients (80.7%) responded and answered the 
BAROS questions; 101 with comorbidities and 54 without.    
We excluded patients with hormonal disorders and other pathologies preoperatively. 
Because gastric banding is not appropriate for every patient, we performed a thorough 
psychological evaluation of all the patients. When needed, we offered preoperative and 
postoperative psychological and dietary support. 
We performed the operation using a pars flaccida technique and secured the band with 1-3 
stitches (fundus to the left crus and pouch). 
To determine if there is a correlation between EWL and participation in the support group, we 
performed a statistical analysis on the 192 patients who were monitored for more than 1 year. 
Background data statistics included frequency and percentage distributions for categorical 
variables, along with mean values and standard deviations for continuous variables. Pearson 
correlation coefficient was calculated to conduct univariate strength association between EWL 
and the number of visits in the support group. We used the linear regression method for 
calculation of the EWL value (dependent variable) in relation to the number of visits, adjusted 
by age and gender (Figure7, Table 13). Statistical analysis was performed with the SPSS 15.0 
software (SPSS Inc., Chicago, Il). P value < 0.05 was marked as statistically significant. 
3.2 Results 
192 out of 264 patients were monitored for more than one year after the procedure (172 
females and 20 males). 
Weight loss; In the first year, patients lost 23.4 kg on average (-1.1 - 52.9); (female 23.3 kg, 
range -1.1 - 52.9; male 24.6 kg, range 8.4 - 47.7).  
Two years after the operation, 118 patients (106 females and 12 males) lost 31.4 kg on 
average, range -6.3 to 63.8 (female 31.4 kg, range -6.3 – 63.8; male 29.9, range 11.0 – 51.9). 
Three years after the operation, 72 patients (67 females and 5 males) lost 33.7 kg on average, 
range 6.2 to 69.0. Fig. 4. 
EWL; One year after the operation, EWL was 50.3% on average, range -2.0 -145.3% (female 
51.7%, range -2.0 - 145.3%; male 38.3%, range 12.2 - 51.2%). 
Two years after the operation, EWL was 65.6% on average (-11.2 to 135.9%); (female 68.0%, 
range -11.2 – 135.9%; male 43.9%, range 19.0 - 62.5%). 
Three years after the operation, EWL was 69.8% on average, range 17.0 to 134.9. Fig 5 
BMI; The average BMI of all patients before the operation was 42.4 kg/m2 (range 34.5 – 
59.0), 42.0 kg/m2 for females (range 34.5 – 59.0),and 44.0 kg/m2 for males (range 34.8 – 55.7). 
One year after the procedure, the average BMI was 34.0 kg/m2 for all patients (range 21.9 – 
51.2), 33.6 kg/m2 for females (range 21.9 – 51.2), and 37.4 kg/m2 for males (range 29.0 – 45.5). 
Two years after the procedure, the average BMI was 31.4 kg/m2 (range 20.2 – 47.9), 31.0 
kg/m2 for females (range 20.2 – 47.9), and 36.4 kg/m2 for males (range 31.8 – 43.0). 
www.intechopen.com
Gastric Banding and Bypass for Morbid Obesity – 
Preoperative Assessment, Operative Techniques and Postoperative Monitoring 167 
 
Fig. 4. Weight loss 
 
Fig. 5. EWL 
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Fig. 6. BMI reduction: 
 
 ALL FEMALE MALE 
No 264 224 40 
AGE 41.0(17.2-68.8) 41.0(19.5-68.8) 41.2(17.2-61.9) 
BMI 42.4(34.5-59.0) 42.0(34.5-59.0) 44.0(34.8-55.7) 
Table 6. Patients 
 
YEAR OF THE SURGERY PTS WITH BAND WITHOUT BAND LOST 
1st 11 4(36.4%) 6(54.5%) 1(9.1%) 
2nd 76 68(89.5%) 8(10.5%) 0 
3rd 49 46(94%) 1(2%) 2(4%) 
4th 75 74(99%) 0 1 
5th 53 53(100%) 0 0 
ALL 264 245(92.8%) 15(5.7%) 4(1.5%) 
Table 7. Monitoring 
Three years after the procedure, the average BMI of all patients was 30.8 kg/m2 (range 22.4 – 
44.0) Fig. 6, Table 10a-c 
Reoperations; We performed 15 re-operations: 4 (1.5%) bands were removed due to 
dilatation of the pouch and slippage, 6 (2.3%) due to insufficient reduction of the body 
weight, and one each (0.4%) due to migration, outlet obstruction, band leakage, intra 
abdominal abscess, and personal reasons. 
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Resolution of comorbidities; The main obesity-related comorbidities resolved as shown in 
table 6. We had 31 patients with diabetes. 13 of them (41.9%) improved, 17 (54.8%) had 
complete resolution of the disease, and one patient (3.2%) was lost to follow up.  Out of 51 
patients with hypertension, 21 (41.2%) improved, 28 (54.9%) had complete resolution of the 
disease, one patient (2.0%) showed no change, and one patient (2.0%) was lost to follow up. 
Out of 17 patients with hyperlipidemia, 6 (35.3%) improved, 9 (52.9%) had complete 
resolution of the disease, one patient (5.9%) showed no change, and one patient (5.9%) was 
lost to follow up.  
Complications; There was no perioperative mortality, no pulmonary embolism, no stomach 
wall lesions, and no hemorrhage. 
Early complications (within 1 month after the procedure): 1 (0.4%) intra abdominal abscess 
and 1 (0.4%) outlet obstruction.  
Late complications (more than 1 month after the procedure): 1 (0.4%) band migration, 4 
(1.5%) slippages/dilatations, and 1 (0.4%) band leakage. 
Statistical analysis of support group visits and EWL; With the Pearson coefficient of r=0.58 
(p<0.001), we are able to conclude that there is a “moderate to strong” correlation (r>0.5 is 
usually interpreted as a strong correlation) between the number of visits in the support 
group and EWL. The distribution between EWL and the number of visits is shown by a 
scattered plot in Table 12. 
Table 12 shows that the number of visits has a statistically significant impact on EWL, while 
age and gender do not significantly correlate with the EWL. 
Quality of life evaluation; The average BAROS score was a grade of “good” in both groups: 
4.85 in the group with comorbidities and 2.64 in the group without comorbidities. 155 out of 
193 patients (80.7%) answered the QoL questionnaire. In the group of 54 patients with 
comorbidities, the average score for QoL was 1.83 (range -0.4 – 3.0), 1.53 for EWL (range 0 – 
3), and 1.66 for medical condition (range 0 – 3). In the group of 101 patients without 
comorbidities, the average score for quality of life (QoL) was 1.72 (range -2.5 – 3.0), and 1.48 
for EWL (range 0 – 3), Table 13. 
 
Year of the surgery 1st 2nd 3rd 4th 5th TOTAL 
migration  1    1(0.4%) 
Slippage/dilatation 1 2 1   4(1.5%) 
Insuficient weight loss 3 3    6(2.3%) 
Outlet obstruction 1     1(0.4%) 
Band leakage 1     1(0.4%) 
Personal reasons  1    1(0.4%) 
Intra abdominal abscess  1    1(0.4%) 
Table 8. Reasons for removing of the band 
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Characteristics Patient group (N=192) 
EWL 50.3±24.2 
Gender (%)  
male 12.4 
female 87.6 
Age in years 41.7±12.2 
Number of visits 2.8±2.0 
Table 9. Background data of the patients participating the support group 
 
Monitored years/ 
No of patients 
Weight loss(kg) EWL(%) BMI(kg/m2) 
>1/192 23.4(-1.1-52.9) 50.3(-2.0-145.3) 34.0(21.9-51.2) 
>2/118 31.4(-6.3-63.8) 65.6(-11.2-135.9) 31.4(20.2-47.9) 
>3/72 33.7(6.2-69.0) 69.8(17.0-134.9) 30.8(22.4-44.0) 
>4/4 35.1(25.1-51.7) 82.2(69.0-97.3) 27.6(25.4-29.7) 
Table 10.a) Results all 
 
Monitored years/ 
No of patients 
Weight loss(kg) EWL(%) BMI(kg/m2) 
>1/172 23.3(-1.1-52.9) 51.7(-2.0-145.3) 33.6(21.9-51.2) 
>2/106 31.4(-6.3-63.8) 68.0(-11.2-135.9) 31.0(20.2-47.9) 
>3/67 33.7(6.2-69.0) 71.6(19.5-134.9) 30.3(22.4-41.6) 
>4/4 35.1(25.1-51.7) 82.2(69.0-97.3) 27.6(25.4-29.7) 
Table 10.b) Results – female 
 
Monitored years/ 
No of patients 
Weight loss(kg) EWL(%) BMI(kg/m2) 
>1/20 24.6(8.4-47.7) 38.3(12.4-79.7) 37.4(29.0-45.5) 
>2/12 29.9(11.0-51.9) 43.9(19.0-62.5) 36.4(31.8-43.0) 
>3/5 33.5(12.2-51.2) 45.0(17.0-60.6) 36.2(30.9-44.0) 
>4/4    
Table 10.c) Results – male 
 
 all improved resolved No change No data 
Diabetes  31 13(41.9%) 17(54.8%)  1(3.2%) 
Hypertension  51 21(41.2%) 28(54.9%) 1(2.0%) 1(2.0%) 
Hyperlipidemia  17 6(35.3%) 9(52.9%) 1(5.9%) 1(5.9%) 
Table 11. Resolution of comorbidities 
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Fig. 7. Relation between number of visits and EWL 
 
 Beta t p 
Number of visits 0.56 9.32 <0.001 
Age -0.03 -0.57 0.571 
Female gender 0.09 1.45 0.148 
R2=0.341 
Table 12. Linear model to calculate EWL 
 
 QoL EWL Medical condition Total score 
Comorbidity group 1.83(-0.4-3.0) 1.53(0-3) 1.66(0-3) 4.85(0.2-8.4) 
Without comorbidity 1.72(-2.5-3.0) 1.48(0-3) 2.64(-2.5-5.9) 
Table 13. BAROS 
4. Bariatric procedures, laparoscopic sleeve gastrectomy (LSG) 
LSG is a resection of the stomach along the greater curvature. For high-risk obese patients 
seeking gastric bypass, it may be safer and more effective to first conduct a laparoscopic 
sleeve gastrectomy, and then perform a Roux-en-Y procedure later, researchers reported at 
the Society of American Gastrointestinal Endoscopic Surgeons8. Laparoscopic sleeve 
gastrectomy has been advocated as the first of a 2-stage procedure for the high-risk, super-
obese patient. More recently, LSG has been studied as a single-stage procedure for weight 
loss in the morbidly obese. LSG has been shown in initial studies to produce excellent excess 
weight loss comparable with laparoscopic Roux-en-Y gastric bypass in many series with a 
very low incidence of major complications and death10.LSG will cause many patients to lose 
weight, which could make them better candidates for the higher morbidity, higher mortality 
r=0.58; 
p<0.001 
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Roux-en-Y gastric bypass. The data appear to show that LSG only causes short-term weight 
loss, so in most cases, the Roux-en-Y procedure will likely be required.   
5. Discussion 
Our results are comparable to the ones published in the literature (Schirmer, 2004, Wise et al., 
2001, Lippincott & Wilkins, 2003, Gravante et al., 2007 ). In our case, there is a noticeable 
difference of the early results when we did not have such a strict interdisciplinary approach. 
Several of our first 20 cases were not really successful because of insufficient psychological and 
dietary treatment before the operation: our first patient had psychological problems we failed 
to recognize. She was willing to cooperate, but she did not tell us about her son who used 
drugs and husband who was an alcoholic. After two years we performed LSG on her. At the 
beginning, we did not have a psychologist of our own. Our second patient could not change 
his eating habits, which resulted in slippage of the band. We would be able to predict this 
deviation today. Next patient from the beginning ate too much and too fast- 5 weeks after the 
operation an outlet obstruction ocured and we had to remove the band. Among the first ten 
patients, failiures could be prevented with good psychological evaluation. AGB is a method 
where patients should be very motivated and willing to cooperate. If one has many of the 
obsessive-compulsive elements in his character, we cannot expect good results. Frequent 
monitoring after the operation in a support group is very important as well as immediate 
emptying of the band if necessary. The diference between those patients who participated in 
the support group and those who did not is significant- EWL of the group who did not 
participate in the support group was significantly lower than that of the group where patients 
were present at least 5 times during the first year (30.7% vs 75.7%). 
AGB has indeed been shown in a randomized study to be superior to its open counterpart 
regarding hospital stay and readmissions (O’Brien et al., 2002). AGB is usually reported to be 
associated with a low perioperative complication rate and a very low mortality. The mean 
excess weight loss after 2 or more years is between 45% and 65% (Belachew et al., 2002, 
Zinzindohoue et al., 2003, Ceelen et al., 2003) ours is 66.9%. Commonly reported long-term 
complications are band slippage with or without pouch dilatation, band erosion (migration of 
the band into the stomach), band or port infection, and leaks from the band, port, or 
connecting tube. Overall, late morbidity affects between 6% and 25% of the patients in series 
including more than 100 patients. The frequency of each of these complications varies among 
series. For instance, band slippage occurs at rates between 0.6% and 20%, band erosion at rates 
between 0% and 11%, and leaks at rates between 1.4% and 26%. We have had two slippages 
among 120 patients in 2 years, no migrations and no leaks. These late complications lead to 
reoperations in up to 20% of the patients. Our reoperation rate is 7,5%. We are satisfied of not 
having fatalities, stomach wall lesions, pneumothorax, haemorrhages, port system 
complications wound ifections…(literature : fatalities up to 2,1%, somach wall lesions up to 
3,5%,haemorrhage up to 2,0%, port or band system complications up to 10,4%...) (Miller, 2005). 
The GBP procedure has generally been considered the gold standard based on the availability 
of long-term results that achieve an approximate 70% excess body weight loss over 7 to 10 
years. The correction of comorbid conditions has been reported for diabetes mellitus (83%), 
hypertension (69%), gastric reflux (100%), urinary stress incontinence, and degenerative joint 
disease (Schauer et al., 2003, Sugerman et al., 2003, Perry et al., 2004, Lara et al., 2005). Flum 
and others have shown a significant improvement in survival for a group of patients treated 
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with surgery compared with conventional treatment (Flum & Delinger, 2004). The cost 
analysis shows that the recovery of procedure cost is achieved in 12 months (Gallagher et al., 
2003). When one considers the improvements in life expectancy, resolution of severe chronic 
disease, improvement in quality of life, and reduction in risk of cancer, there is hardly a 
procedure or medication in the history of medicine that can equal the GBP procedure. 
Compared to published results our program in laparoscopic bariatric surgery is successful. 
Significant complications occurred in a few patients as a result of anastomotic leaks (LSG). 
Fortunately, this and other complications have decreased progressively with experience and 
improved surgical techniques and new material. We had one abscess in the wound after 
sleeve. Other complications did not occur at an increased rate. Weight loss was acceptable 
and resolution of comorbidities occurred as anticipated. With more experience, we perform 
more and more GBP procedures. At the very beginning we used circular stapler, now we are 
performing gastro entero anastomosis with a linear one. 
6. Conclusions 
Bariatric surgery has proven to be the best treatment for morbid obesity. AGB is the 
procedure with less complications, but it is not convenient for everyone. Good preoperative 
psychological evaluation has proven to be necessary. Super obese patients have a high risk 
of perioparative complications but AGB is not the best choice. We prefere LSG in such cases. 
The results suggest that the surgeons practicing bariatric surgery should make efforts to 
learn the skills for laparoscopic gastric bypass, because it is likely to become the standard of 
care for the surgical treatment of obesity.  
Good results can be expected with interdisciplinary approach after the learning curve. After 
the operation, the results are significantly better when the patients are regularly monitored. 
Our study shows that results are the best when they participate in the support group of 
operated patients guided by a psychologist - especially in patients who underwent gastric 
banding. 
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